Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Key facts

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Principal Investigator

Irini Sereti, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment

950 enrolled

Eligibility

18 years · All sexes

Timeline

2009

Study locations (1)

• National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Idiopathic CD4 lymphocytopenia

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT02015013
  Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
  National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Idiopathic CD4 lymphocytopenia →